A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines
Objective In this study we prepared a novel formulation of liposomal doxorubicin (L- DOX). The drug dose was optimized by analyses of cellular uptake and cell viability of osteosarcoma (OS) cell lines upon exposure to nanoliposomes that contained varying DOX concentrations. We intended to reduce th...
Main Authors: | Fateme Haghiralsadat, Ghasem Amoabediny, Mohammad Hasan Sheikhha, Tymour Forouzanfar, Javad Mohammadnejad, Behrouz Zandieh-doulabi |
---|---|
Format: | Article |
Language: | English |
Published: |
Royan Institute (ACECR), Tehran
2017-05-01
|
Series: | Cell Journal |
Subjects: | |
Online Access: | http://celljournal.org/journal/article/12049/download |
Similar Items
-
New Approach for the Synthesis, Entrapment of Hydrophilic Drugs and Evaluation of Physico-Chemical Characteristics of PH-sensitive Nano-Liposome: Improving Therapeutic Efficacy of Doxorubicin in Order to Treatment Bone Tumor and Reducing the Side Effects of Doxorubicin
by: Fa Haghiralsadat, et al.
Published: (2017-01-01) -
Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
by: Haghiralsadat F, et al.
Published: (2018-07-01) -
A comparison between liposomal and nonliposomal formulations of doxorubicin in the treatment of cancer: An updated review
by: Yik Hoe Ngan, et al.
Published: (2016-01-01) -
Doxorubicin Loaded Liposomal Nanoparticles Containing Quantum Dot for Treatment of Breast Cancer
by: Javad Shahabi, et al.
Published: (2019-10-01) -
Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma
by: Martina Godel, et al.
Published: (2020-06-01)